Glaxosmithkline Pharmaceuticals informs about issuance of duplicate share certificate

11 Jul 2019 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company Karvy Fintech has received request for issue of duplicate Share Certificates from Santur Ganapathi Vaman Mallya. The Company shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2040.25 97.60 (5.02%)
24-Apr-2024 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1491.00
Dr. Reddys Lab 5980.00
Cipla 1382.60
Zydus Lifesciences 930.30
Lupin 1586.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.